RGC (Regencell Bioscience Holdings) Book Value per Share: $0.00 (As of Dec. 2025)


RGC Regencell Bioscience Holdings Ltd RGC
31 GF Score
Price $6.45
! 2 Warning Signs
View Full Analysis

What is Regencell Bioscience Holdings Book Value per Share?

Regencell Bioscience Holdings RGC +9.08% 31 Book Value per Share is $0.00 as of Dec. 2025. GuruFocus rates RGC with a GF Score™ of 31/100. The stock has 2 warning signs investors should review.

Regencell Bioscience Holdings's book value per share for the quarter that ended in Dec. 2025 was $0.00.

During the past 12 months, Regencell Bioscience Holdings's average Book Value Per Share Growth Rate was -41.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -34.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Regencell Bioscience Holdings was -34.10% per year. The lowest was -34.10% per year. And the median was -34.10% per year.

Regencell Bioscience Holdings's current price is $6.45. Its book value per share for the quarter that ended in Dec. 2025 was $0.00. Hence, today's PB Ratio of Regencell Bioscience Holdings is 645.00.

During the past 7 years, the highest P/B Ratio of Regencell Bioscience Holdings was 2975.00. The lowest was 0.00. And the median was 0.00.


Regencell Bioscience Holdings  (NAS:RGC) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Regencell Bioscience Holdings Book Value per Share Related Terms


Regencell Bioscience Holdings Book Value per Share Historical Data

* Premium members only.

The historical data trend for Regencell Bioscience Holdings's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regencell Bioscience Holdings Book Value per Share Chart

Regencell Bioscience Holdings Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Book Value per Share
Get a 7-Day Free Trial -0.01 0.04 0.02 0.02 0.01

Regencell Bioscience Holdings Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.01 0.01 0.00

RGC vs SUPN, BCRX, PBH: Book Value per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Regencell Bioscience Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regencell Bioscience Holdings PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Regencell Bioscience Holdings's PB Ratio distribution charts can be found below:

* The bar in red indicates where Regencell Bioscience Holdings's PB Ratio falls into.


RGC
31GF Score
Regencell Bioscience Holdings Ltd RGC
Book Value per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Regencell Bioscience Holdings Book Value per Share Calculation

Regencell Bioscience Holdings's Book Value Per Share for the fiscal year that ended in Jun. 2025 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(4.86-0.00)/494.49
=0.01

Regencell Bioscience Holdings's Book Value Per Share for the quarter that ended in Dec. 2025 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1.22-0.00)/494.49
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Frequently Asked Questions Learn more about Book Value per Share →
What does a Book Value per Share of $0.00 mean?
Regencell Bioscience Holdings (RGC) has a Book Value per Share of $0.00 as of Dec. 2025. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Regencell Bioscience Holdings and its competitors.
Is Regencell Bioscience Holdings' Book Value per Share too high?
Regencell Bioscience Holdings' current Book Value per Share is $0.00. Overall, Regencell Bioscience Holdings has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Regencell Bioscience Holdings' Book Value per Share compare to SUPN and BCRX?
Regencell Bioscience Holdings' Book Value per Share of $0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Drug Manufacturers company?
A good Book Value per Share depends on the Drug Manufacturers industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Regencell Bioscience Holdings and its competitors. Regencell Bioscience Holdings's current Book Value per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regencell Bioscience Holdings stock overvalued right now?
Regencell Bioscience Holdings (RGC) has a current Book Value per Share of $0.00. The current Book Value per Share is $0.00. Regencell Bioscience Holdings' overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Regencell Bioscience Holdings (RGC), the current Book Value per Share is $0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Regencell Bioscience Holdings Business Description

Address 29 Leighton Road, 9th Floor, Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
31GF Score

Get the complete analysis for RGC

Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.45
Price